Lv6
2248 积分 2023-10-16 加入
Prognostic impact of NPM1 and FLT3 mutations in patients with AML in first remission treated with oral azacitidine
8小时前
待确认
ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients
20小时前
待确认
Comprehensive genetic analysis by targeted sequencing identifies risk factors and predicts patient outcome in Mantle Cell Lymphoma: results from the EU-MCL network trials
20小时前
已完结
Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma
20小时前
已完结
Zanubrutinib, Obinutuzumab, and Venetoclax for First-Line Treatment of Mantle Cell Lymphoma with a TP53 Mutation
1个月前
已完结
TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy
1个月前
已完结
Leukemic presentation in nodal mantle cell lymphoma is characterized by frequent SOX11 negativity, a poor risk genomic landscape including higher <i>TP53</i> alterations, and worse overall survival
2个月前
已完结
TP53 Gene Status can Promote Sensitivity and Resistance to Chemotherapeutic Drugs and Small Molecule Signal Transduction Inhibitors
2个月前
已完结
Unraveling MCL biology to understand resistance and identify vulnerabilities
2个月前
已完结
Mutations of ATM Confer a Risk of Inferior Survival in Patients with TP53-wild Type Mantle Cell Lymphoma
2个月前
已关闭
皖公网安备34019202002308
